Behavioural and anatomical effects of systemically administered leukemia inhibitory factor in the SOD1G93A G1H mouse model of familial amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

Behavioural and anatomical effects of systemically administered leukemia inhibitory factor in the SOD1G93A G1H mouse model of familial amyotrophic lateral sclerosis

Published:2003-08 Issue:1 Volume:982 Page:92-97
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Azari Michael F.,Lopes Elizabeth C.,Stubna Chantelle,Turner Bradley J.,Zang Dawei,Nicola Nicos A.,Kurek John B.,Cheema Surindar S.

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference27 articles.

1. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group;Neurology,1996

2. A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III);Neurology,1999

3. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines;Arakawa;J. Neurosci.,1990

4. Leukemia inhibitory factor ameliorates muscle fiber degeneration in the mdx mouse;Austin;Muscle Nerve,2000

5. Leukemia inhibitory factor by systemic administration rescues spinal motor neurons in the SOD1 G93A murine model of familial amyotrophic lateral sclerosis;Azari;Brain Res.,2001

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis;IBRO Reports;2019-06

2. Efficacy of leukemia inhibitory factor as a therapeutic for permanent large vessel stroke differs among aged male and female rats;Brain Research;2019-03

3. The role of the leukemia inhibitory factor receptor in neuroprotective signaling;Pharmacology & Therapeutics;2018-03

4. Animal Models of Neurological Disorders;Drug Discovery and Evaluation: Pharmacological Assays;2016

5. Animal Models of Neurological Disorders;Drug Discovery and Evaluation: Pharmacological Assays;2016